
FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
WASHINGTON (AP) — Health advisers met Thursday to review more than a half-dozen peptides, unproven substances that have become a growing wellness trend despite little evidence they are safe or effective. In the first of several votes, the panel of Food and Drug Administration experts narrowly voted 8-6 in favor of broadening access to a chemical called BPC-157, one of the most popular peptides among longevity and wellness influencers. One panel member abstained from voting. The two-day has F...
Read MoreThu, 23 Jul 2026
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
- Rei Ami from KPop Demon Hunters and comedian Ken Jeong take a bite out of Shark Week
Wed, 22 Jul 2026
- Florida researchers bring endangered elkhorn coral ashore to protect them
- 2,000 volunteers join a painstaking effort to restore massive skeleton of prehistoric predator
- Private mission launches to extend life of out-of-gas communication satellites
Mon, 20 Jul 2026
- Oystercatchers, known for sharp bills and beady eyes, are making a comeback thanks to conservation
Sun, 19 Jul 2026
- 5.5 magnitude earthquake hits Perus Andes region and kills at least 6 people
Fri, 17 Jul 2026
- Far above the Earth, NASAs Apollo lunar lander put astronauts on the moon
- Wildfire smoke kills tens of thousands of people a year. Heres how it attacks the body
- SpaceX Starship launch aborted on the pad at the last moment
- Weather conditions again brought devastating floods to a vulnerable swath of Texas
----------
Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
CoreComm is not responsible for content on external sites. Please review the privacy and security policies of each vendor before making online purchases or providing personal information. Forecast Information Provided by AccuWeather.

Copyright © 1996 - 2026 CoreComm Internet Services, Inc. All Rights Reserved. | View our